Case Study

COVID-19 Vaccine Development

Source: Trialbee AB
iStock-1319551550-vaccine-covid

A global pharmaceutical company wanted to enroll representative cohorts of diverse populations in support of its work to develop a vaccine for COVID-19 in the United States. Faced with poor enrollment among non-white patients (only 24% of total enrollees), recruitment and enrollment activity was paused in August of 2020. After pausing all recruitment and enrollment activities in August 2020, Trialbee helped the sponsor to reach its enrollment representation goals just two months later.

To learn more about Trialbee, visit their Clinical Leader page.

VIEW THE CASE STUDY!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader